Neogene Therapeutics
ExitedNeogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.
Total raised
€93M
€93,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2020-09
latest 2020-09
Funding by year
EUR raised per yearFunding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-14 | Other | €93M | EcoR1 Capital,Jeito Capital,Syncona Partners LLP | View deal → |
Exit
Type
acquisition
Date
Nov 2022
Value
€310M
Acquiror
AstraZeneca (UK)
Related news
- AstraZeneca to Acquire Neogene Therapeutics, for up to $320Mfinsmes.com · 2022-11
- labiotech.eu
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech